Startup Permedio, managed by the CEO Stefan Wöhrer, CERN representative Benjamin Frisch and BIC project manager Julia Uhlik met with the CERN CollSpotting Group under the lead of Jean-Marie Le Goff.
Permedio shared their vision of how to enbetter the lives of people with the services of its Center for Personalised Medicine located in Neunkirchen, Lower Austria.
Permedio operates genetical analyses for individual patients to test the tolerance and impact of medical drugs which is done on the basis of clinically validated, international studies . As this business goal requires the handling of very large and complex sets of data, CERN is the most favourable and competent partner for Permedio to guarantee an optimized visualization output for reporting tools under development.
During the meeting the incubation agenda was set with all requirements that also foresee an indepth engagement in data science and information retrieval on side of the startup Permedio. The BIC is enthusiastic about the forthcoming cooperation talks to ensure an innovative and novel product being introduced to the Austrian health tech ecosystem soon
